Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

QGEN Company Profile and Key Details

NYSE : QGEN

Qiagen N.V.

$42.63
-0.005-0.01%
Open: 10:58 AM
55.16
B-ESG ScoreESG Rating

Price Chart

Stock Price Today

Qiagen N.V. (QGEN) stock declined over -0.01%, trading at $42.63 on NYSE, down from the previous close of $42.63. The stock opened at $43.16, fluctuating between $42.46 and $43.18 in the recent session.

Stock Snapshot

42.63
Prev. Close
9.21B
Market Cap
42.46
Day Low
112.17
P/E Ratio
0.38
EPS (TTM)
1.34
Cash Flow per Share
43.16
Open
216.12M
Number of Shares
43.18
Day High
99.52%
Free Float in %
17.2
Book Value
208.52K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Apr 29, 202542.5043.0342.4042.63771.49K
Apr 28, 202542.5042.6042.0442.47977.49K
Apr 25, 202542.5042.5941.8242.07877.92K
Apr 24, 202542.6043.1342.2943.061.21M
Apr 23, 202542.3943.0042.2042.321.29M
Apr 22, 202541.6542.5541.5142.341.3M
Apr 21, 202540.6140.8740.3140.481.07M
Apr 17, 202540.6741.1240.0040.711.73M
Apr 16, 202541.7641.8040.9141.441.76M
Apr 15, 202542.1343.8841.4041.532.4M
Apr 14, 202541.8642.4641.7342.321.08M
Apr 11, 202540.9142.4040.7841.981.57M
Apr 10, 202540.0740.5838.9740.051.23M
Apr 09, 202540.0641.6539.0941.432.62M
Apr 08, 202540.4140.5338.5838.801.38M
Apr 07, 202539.3141.3038.6840.312.94M
Apr 04, 202539.6139.7438.1338.261.75M
Apr 03, 202541.4441.4439.8340.372.29M
Apr 02, 202539.3540.1939.3240.021.37M
Apr 01, 202540.1840.2039.3839.501.52M

Contact Details

Venlo, 5912 PL

Netherlands

https://www.qiagen.com317 735 56600

About Company

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.

Company Information

Employees5067
Beta0.62
Sales or Revenue$1.97B
5Y Sales Change%0.333%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Diagnostics & Research

Frequently Asked Questions

What is the current Qiagen N.V. (QGEN) stock price?
Qiagen N.V. (NYSE: QGEN) stock price is $42.63 in the last trading session. During the trading session, QGEN stock reached the peak price of $43.18 while $42.46 was the lowest point it dropped to. The percentage change in QGEN stock occurred in the recent session was -0.01% while the dollar amount for the price change in QGEN stock was -$0.01.
QGEN's industry and sector of operation?
The NYSE listed QGEN is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Qiagen N.V. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of QGEN?
Dr. Jonathan G. Sheldon Ph.D.
Senior Vice President of Qiagen Digital Insights Bus. Area
Dr. Roland Sackers
Chief Financial Officer, MD & Member of Management Board
Mr. Thierry Bernard
Chief Executive Officer, MD & Member of Management Board
Mr. Thomas Neidert
Vice President of Global Treasury
Mr. John Gilardi
Vice President of Corporation Communications & Investor Relations
Ms. Stephany Foster
Senior Vice President & Head of HR
Dr. Thomas Theuringer
Senior Director & Head of External Communications
Mr. Jean-Pascal Viola
Senior Vice President & Head of Molecular Diagnostics Bus. Area
Mr. Antonio Santos
Senior Vice President & Head of Global Operations
Dr. Thomas Schweins
Senior Vice President of Life Science Bus. Area
How QGEN did perform over past 52-week?
QGEN's closing price is 13.29% higher than its 52-week low of $37.63 where as its distance from 52-week high of $47.93 is -11.06%.
How many employees does QGEN have?
Number of QGEN employees currently stands at 5,067.
Link for QGEN official website?
Official Website of QGEN is: https://www.qiagen.com
How do I contact QGEN?
QGEN could be contacted at phone 317 735 56600 and can also be accessed through its website. QGEN operates from Hulsterweg 82, Venlo, 5912 PL, Netherlands.
How many shares of QGEN are traded daily?
QGEN stock volume for the day was 208.52K shares. The average number of QGEN shares traded daily for last 3 months was 1.35M.
What is the market cap of QGEN currently?
The market value of QGEN currently stands at $9.21B with its latest stock price at $42.63 and 216.12M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph